Sitemap

September 20, 2020 Articles

Filter by Available Specialty
  1. Addition of abemaciclib to endocrine therapy extends invasive DFS in breast cancer subset
  2. Data reinforce adjuvant osimertinib as ‘practice-changing treatment’ in NSCLC subset
  3. Medacta releases 2020 half-year financial results
  4. Radiotherapy fails to extend DFS after complete resection in NSCLC
  5. September’s top five retina articles
  6. Spartalizumab-based combination fails in BRAF-mutated advanced melanoma
  7. Study shows similar hospitalization, ICU admission rates among kids with COVID-19, flu
  8. Top news from AHA Hypertension: Trends in BP control, hypertension in COVID-19 and more